Sophia Genetics SA (SOPH) — Strategic Asset Allocation Index
Sophia Genetics SA (SOPH) has a Strategic Asset Allocation Index of 14.0% as of September 2023. Strategic assets (PP&E of $22.14 Million plus long-term investments of $-) total $22.14 Million, measured against net assets of $158.44 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check SOPH cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Sophia Genetics SA Strategic Asset Allocation Index (2018–2022)
This chart shows how Sophia Genetics SA's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2022. As of September 2023, the index stands at 14.0%, representing strategic assets of $22.14 Million against net assets of $158.44 Million USD. See SOPH free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Sophia Genetics SA (2018–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Sophia Genetics SA from 2018 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see SOPH stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 10.7% | $21.40 Million | $21.40 Million | $- | $200.13 Million | ▲ +4.9 pp |
| 2021 | 5.8% | $15.96 Million | $15.96 Million | $- | $275.40 Million | ▼ -0.5 pp |
| 2020 | 6.3% | $6.31 Million | $5.54 Million | $775.00K | $100.51 Million | ▼ -24.4 pp |
| 2019 | 30.7% | $6.82 Million | $6.45 Million | $373.00K | $22.25 Million | ▲ +30.2 pp |
| 2018 | 0.5% | $260.00K | $- | $260.00K | $54.82 Million | — |